PIA
NXTM

Piedmont Investment Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Piedmont Investment Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,142
Closed -$32K – 2859
2018
Q2 		$32K Buy
+1,142
New +$30.6K ﹤0.01% 1453

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Piedmont Investment Advisors's NXTM Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 1,142 shares — an estimated $32K sold.

Piedmont Investment Advisors first reported a position in NXTM in Q2 2018 and held it in 1 quarter. The position peaked at $32K in Q2 2018. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 1,142 NxStage Medical Inc. shares in Q3 2018, an estimated $32K.
  • Piedmont Investment Advisors first reported a position in NxStage Medical Inc. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's NxStage Medical Inc. position peaked at $32K in Q2 2018.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.